Crescent Biopharma Inc.

NASDAQ: CBIO · Real-Time Price · USD
13.89
-0.04 (-0.29%)
At close: Aug 15, 2025, 3:59 PM
14.06
1.19%
After-hours: Aug 15, 2025, 07:27 PM EDT

Crescent Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
11.81M 21.67M 44.35M
Short-Term Investments
n/a n/a 2.5M
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
29.03M 168K 472K
Receivables
19.59M 5M 1.82M
Inventory
6.34M n/a n/a
Other Current Assets
27.05M 1.54M 2.81M
Total Current Assets
64.79M 28.21M 51.48M
Property-Plant & Equipment
25.7M 70K 3.71M
Goodwill & Intangibles
273K n/a n/a
Total Long-Term Assets
60.62M 238K 4.19M
Total Assets
35.62M 28.44M 55.66M
Account Payables
108K 194K 6.42M
Deferred Revenue
n/a n/a 230K
Short-Term Debt
713K 38K 1.98M
Other Current Liabilities
15.86M 16.59M 5.54M
Total Current Liabilities
19.52M 16.82M 14.16M
Long-Term Debt
885K n/a 408K
Other Long-Term Liabilities
6.6M 33.31M n/a
Total Long-Term Liabilities
7.49M 33.31M 408K
Total Liabilities
27M 50.13M 14.57M
Total Debt
1.6M 38K 2.38M
Common Stock
1K 37K 31K
Retained Earnings
-73.45M -410.94M -402.69M
Comprehensive Income
-2.6M n/a n/a
Shareholders Equity
-15.48M -21.69M 41.09M
Total Investments
n/a n/a 2.5M